PD-L1 binding peptide identified by phage peptide display inhibits PD-1/PD-L1 interaction and activates T cells

被引：0
|
作者：
Gurung, Smriti [1 ]
Khan, Fatima [1 ]
Lee, Soo-Woong [1 ]
Yoon, Jaewon [1 ]
Lee, Byungheon [1 ]
机构：
[1] Kyungpook Natl Univ, Daegu, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1000
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
    Li, Chunlin
    Zhang, Nengpan
    Zhou, Jundong
    Ding, Chen
    Jin, Yaqing
    Cui, Xueyuan
    Pu, Kefeng
    Zhu, Yimin
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (02) : 178 - 188
  • [2] mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)
    Kamalinia, Golnaz
    Engel, Brian J.
    Srinivasamani, Anupallavi
    Grindel, Brian J.
    Ong, Justin N.
    Curran, Michael A.
    Takahashi, Terry T.
    Millward, Steven W.
    Roberts, Richard W.
    ACS CHEMICAL BIOLOGY, 2020, 15 (06) : 1630 - 1641
  • [3] The rational design and evaluation of a peptide inhibitor of the PD-1/PD-L1 interaction
    Boohaker, Rebecca J.
    Sambandam, Vijaya
    Suto, Mark
    Xu, Bo
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Blocking of the PD-1/PD-L1 interaction by an affinity peptide for cancer immunotherapy
    Luo, H.
    Li, X.
    Zhu, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1782 - 1782
  • [5] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [6] Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint
    Magiera-Mularz, Katarzyna
    Kuska, Katarzyna
    Skalniak, Lukasz
    Grudnik, Przemyslaw
    Musielak, Bogdan
    Plewka, Jacek
    Kocik, Justyna
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Sala, Dominik
    Wladyka, Benedykt
    Siedlar, Maciej
    Holak, Tad A.
    Dubin, Grzegorz
    ADVANCED THERAPEUTICS, 2021, 4 (02)
  • [7] Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction
    Hayward, Deanne
    Goddard, Zoe R.
    Cominetti, Marco M. D.
    Searcey, Mark
    Beekman, Andrew M.
    CHEMICAL COMMUNICATIONS, 2024, 60 (63) : 8228 - 8231
  • [8] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
12345